{
  "meta": {
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Princeton",
      "reason_for_recall": "Presence of N-Nitrosodimethylamine (NDMA) impurity above the acceptable daily intake limit",
      "address_1": "One Merck Drive",
      "address_2": "Building 5",
      "product_quantity": "5,432 bottles",
      "code_info": "Lot numbers: AB1234 (Exp 12/2024), CD5678 (Exp 01/2025), EF9012 (Exp 02/2025)",
      "center_classification_date": "20230615",
      "distribution_pattern": "Nationwide distribution to wholesalers and retail pharmacies in all 50 states",
      "state": "NJ",
      "product_description": "Valsartan Tablets USP, 160 mg, 90 count bottles, NDC 0378-5160-90",
      "report_date": "20230622",
      "classification": "Class II",
      "openfda": {
        "application_number": ["ANDA090802"],
        "brand_name": ["VALSARTAN"],
        "generic_name": ["VALSARTAN"],
        "manufacturer_name": ["Mylan Pharmaceuticals Inc."],
        "product_ndc": ["0378-5160"],
        "package_ndc": ["0378-5160-90"],
        "unii": ["80M03YXJ7I"],
        "spl_set_id": ["4b5c5f6d-7e8f-9g0h-1i2j-3k4l5m6n7o8p"]
      },
      "more_code_info": "Manufacturing dates: January 2023 - March 2023",
      "recalling_firm": "Mylan Pharmaceuticals Inc.",
      "recall_number": "D-0001-2023",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "91234",
      "termination_date": "",
      "recall_initiation_date": "20230610",
      "postal_code": "08540-0004",
      "voluntary_mandated": "Voluntary: Firm Initiated",
      "status": "Ongoing"
    }
  ]
}
